GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Capricor Therapeutics Inc (FRA:4LN2) » Definitions » Price-to-Tangible-Book

Capricor Therapeutics (FRA:4LN2) Price-to-Tangible-Book : 8.67 (As of May. 16, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Capricor Therapeutics Price-to-Tangible-Book?

As of today (2024-05-16), Capricor Therapeutics's share price is €4.715. Capricor Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.54. Hence, Capricor Therapeutics's Price to Tangible Book Ratio of today is 8.67.

The historical rank and industry rank for Capricor Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

FRA:4LN2' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.98   Med: 4.2   Max: 295.62
Current: 9.07

During the past 13 years, Capricor Therapeutics's highest Price to Tangible Book Ratio was 295.62. The lowest was 0.98. And the median was 4.20.

FRA:4LN2's Price-to-Tangible-Book is ranked worse than
81.15% of 1231 companies
in the Biotechnology industry
Industry Median: 2.81 vs FRA:4LN2: 9.07

A closely related ratio is called PB Ratio. As of today, Capricor Therapeutics's share price is €4.715. Capricor Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was €0.54. Hence, Capricor Therapeutics's P/B Ratio of today is 8.67.


Capricor Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Capricor Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Capricor Therapeutics Price-to-Tangible-Book Chart

Capricor Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 2.72 2.23 8.01 6.56

Capricor Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.94 44.23 - 6.56 -

Competitive Comparison of Capricor Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Capricor Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Capricor Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Capricor Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Capricor Therapeutics's Price-to-Tangible-Book falls into.



Capricor Therapeutics Price-to-Tangible-Book Calculation

Capricor Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=4.715/0.544
=8.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Capricor Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Capricor Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Capricor Therapeutics (FRA:4LN2) Business Description

Traded in Other Exchanges
Address
10865 Road to the Cure, Suite 150, San Diego, CA, USA, 92121
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Capricor Therapeutics (FRA:4LN2) Headlines

No Headlines